Elevated Lp(a) levels, defined as exceeding 75 nmol/L (30 mg/dl), have consistently and independently been associated to an increased risk of ASCVD (2), coronary heart disease (5), myocardial infarction (6), and stroke (7). This evidence concerns the gene LPA and atherosclerosis.